This tracker provides data on global COVID-19 cases and deaths by country, region, and income-level. Additionally, the tracker reports current closure, economic, and health system policy responses to the COVID-19 pandemic globally. This tracker will be updated as new data are available.
- view as grid
- view as list
This interactive tool, which will be updated regularly, provides the share of the population that has received at least one dose of a COVID-19 vaccine by income-level, region, country, and globally. Additionally, using current rates of first dose administration, the tool estimates whether projected coverage levels will meet certain global targets.
This tracker will be updated regularly to provide data on U.S. COVID-19 vaccine donation deliveries globally.
This page tracks recent state actions to extend Medicaid postpartum coverage, including approved and pending 1115 waivers, legislation that will require the state to seek federal approval through a SPA or 1115 waiver, submitted and approved SPAs, and coverage financed solely with state funds.
Analysis: The Vast Majority of Physicians Accept New Patients, Including Patients With Medicare and Private Insurance
Despite occasional anecdotal reports of people having trouble finding a doctor who takes their insurance, KFF researchers find in a new analysis that the vast majority of non-pediatric office-based physicians accept new Medicare patients, as well as new private insurance patients. Eighty-nine percent of such physicians accepted new Medicare patients…
Most Office-Based Physicians Accept New Patients, Including Patients With Medicare and Private Insurance
This brief examines the share of non-pediatric office-based physicians accepting new patients with Medicare or private insurance and how these rates have changed over time and vary by physician specialties, geographic areas, and physician and practice characteristics across Medicare and private insurance. This analysis further examines the extent to which non-pediatric physicians are opting out of Medicare, by specialty and state.
KFF Analysts Find That Between 5.3 Million and 14.2 Million People Could Lose Medicaid Coverage Following the End of the Public Health Emergency and Continuous Enrollment Requirement, With an Unknown Number Able to Find New Coverage
The Enrollment Growth is Expected to Cost States Over $47 Billion Through FY 2022, But States Will Have Received $100 Billion to Cover New Medicaid Costs and Provide Additional General Fiscal Relief Between 5.3 million and 14.2 million low-income people could lose Medicaid coverage following the end of the public…
Fiscal and Enrollment Implications of Medicaid Continuous Coverage Requirement During and After the PHE Ends
This analysis projects enrollment growth through the end of FY 2022. It examines how much of the enrollment growth can be attributed to baseline, or expected enrollment increases without the pandemic, and how much to the MOE continuous enrollment requirement during the PHE. We explore the costs tied to MOE enrollment growth, estimate how much fiscal relief was provided to states through the enhanced FMAP, and describe scenarios for enrollment going forward.
This brief examines typical enrollment patterns for Medicaid and CHIP and uses 2018 Medicaid claims data to gain insight into the effects of the continuous enrollment requirements by eligibility group. Roughly 2% of Medicaid enrollees come on or leave the program in an average month, although there is variation across eligibility groups. A policy to require continuous enrollment would result in sharp reductions in monthly disenrollment rates and would also reduce monthly enrollment rates due to reductions in churn.
Assessing PEPFAR’s Impact: Analysis of Maternal and Child Health Spillover Effects in PEPFAR Countries
This analysis assesses the association between PEPFAR investments and maternal and child health outcomes. It finds that the program was associated with significant, positive improvement maternal and child health, adding to the evidence base that PEPFAR has had positive health spillover effects beyond just HIV.